Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

Shah VP; Flynn GL; Yacobi A; Maibach HI; Bon C; Fleischer NM; Franz TJ; Kaplan SA; Kawamoto J; Lesko LJ; Marty JP; Pershing LK; Schaefer H; Sequeira JA; Shrivastava SP; Wilkin J; Williams RL

首页> 外文期刊>Pharmaceutical research >Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

【24h】

Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

机译：局部皮肤病学剂型的生物等效性-评价生物等效性的方法。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pharmaceutical research》 |1998年第2期|共5页
作者
Shah VP; Flynn GL; Yacobi A; Maibach HI; Bon C; Fleischer NM; Franz TJ; Kaplan SA; Kawamoto J; Lesko LJ; Marty JP; Pershing LK; Schaefer H; Sequeira JA; Shrivastava SP; Wilkin J; Williams RL;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Dosage Forms; Pharmacokinetics; 剂型; 药代动力学;

机译：Dosage Forms;Pharmacokinetics;剂型;药代动力学;

相似文献

外文文献
中文文献
专利

1. Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. [J] . Shah VP, Flynn GL, Yacobi A, Pharmaceutical research . 1998,第2期

机译：局部皮肤病学剂型的生物等效性-评价生物等效性的方法。
2. Microdialysis sampling and the clinical determination of topical dermal bioequivalence. [J] . McCleverty D, Lyons R, Henry B International Journal of Pharmaceutics . 2006,第1a2期

机译：微透析取样和局部皮肤生物等效性的临床测定。
3. Microdialysis sampling and the clinical determination of topical dermal bioequivalence. [J] . McCleverty D, Lyons R, Henry B International Journal of Pharmaceutics . 2006,第1a2期

机译：微透析取样和局部皮肤生物等效性的临床测定。
4. THE EFFECT OF PENETRATION KINETICS ON THE RESULTS OF THE PILOT STUDY DESCRIBED IN THE FDA GUIDANCE "TOPICAL DERMATOLOGIC CORTICOSTEROIDS: IN VIVO BIOEQUIVALENCE" [C] . C. Leopold International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：穿透动力学对FDA指导书“局部皮肤遗传性糖皮质激素：体内生物等效性”中描述的先导研究结果的影响
5. In-vitro diffusion studies as a model for screening dermatological formulations of isosorbide dinitrate to develop optimum topical drug dosage form. [D] . Rana, Dhavalkumar. 2009

机译：体外扩散研究作为筛选硝酸异山梨酯皮肤病学制剂以开发最佳局部药物剂型的模型。
6. An Update of the Brazilian Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products [O] . Kelen Carine Costa Soares, Gustavo Mendes Lima Santos, Guilherme M. Gelfuso, 2015

机译：巴西监管性生物等效性建议书的批准用于批准通用局部皮肤病药物产品的更新
7. Bioequivalence of Topical Dosage Forms [O] . yush Jain 2014

机译：局部剂型的生物等效性
8. Guidance for Industry: SUPAC-MR: Modified Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation [R] . 1997

机译：行业指南：sUpaC-mR：改良释放固体口服剂型。放大和批准后的变化：化学，制造和控制;体外溶出度测试和体内生物等效性文档

Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.

著录项

相似文献

相关主题

期刊订阅